These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18072267)

  • 41. A novel pancreatic endocrine tumor suppressor gene locus on chromosome 3p with clinical prognostic implications.
    Chung DC; Smith AP; Louis DN; Graeme-Cook F; Warshaw AL; Arnold A
    J Clin Invest; 1997 Jul; 100(2):404-10. PubMed ID: 9218518
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Allelic deletion and mutation of the von Hippel-Lindau (VHL) tumor suppressor gene in pancreatic microcystic adenomas.
    Vortmeyer AO; Lubensky IA; Fogt F; Linehan WM; Khettry U; Zhuang Z
    Am J Pathol; 1997 Oct; 151(4):951-6. PubMed ID: 9327728
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Loss of heterozygosity on chromosome 9p13-23 in microdissected laryngeal squamous cell carcinoma by microsatellite analysis].
    Xu X; An Q; Zhang J; Tang P; Cheng S
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 36(5):367-71. PubMed ID: 12761947
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Von Hippel-Lindau tumour suppressor gene is not involved in sporadic human breast cancer.
    Sourvinos G; Miyakis S; Liloglou TL; Field JK; Spandidos DA
    Tumour Biol; 2001; 22(3):131-6. PubMed ID: 11275790
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma.
    Osada R; Horiuchi A; Kikuchi N; Yoshida J; Hayashi A; Ota M; Katsuyama Y; Melillo G; Konishi I
    Hum Pathol; 2007 Sep; 38(9):1310-20. PubMed ID: 17555795
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Renal cell carcinoma with areas mimicking renal angiomyoadenomatous tumor/clear cell papillary renal cell carcinoma.
    Petersson F; Grossmann P; Hora M; Sperga M; Montiel DP; Martinek P; Gutierrez ME; Bulimbasic S; Michal M; Branzovsky J; Hes O
    Hum Pathol; 2013 Jul; 44(7):1412-20. PubMed ID: 23434146
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chromosome 3p tumor-suppressor gene alterations in cervical carcinomas.
    Herzog CR; Crist KA; Sabourin CL; Kelloff GJ; Boone CW; Stoner GD; You M
    Mol Carcinog; 2001 Mar; 30(3):159-68. PubMed ID: 11301476
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic and epigenetic analysis of the VHL gene in gastric cancers.
    Cao Z; Song JH; Kim CJ; Cho YG; Kim SY; Nam SW; Lee JY; Park WS
    Acta Oncol; 2008; 47(8):1551-6. PubMed ID: 18607865
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Allelic loss at chromosomes 3p, 8p, 13q, and 17p associated with poor prognosis in head and neck cancer.
    Li X; Lee NK; Ye YW; Waber PG; Schweitzer C; Cheng QC; Nisen PD
    J Natl Cancer Inst; 1994 Oct; 86(20):1524-9. PubMed ID: 7932807
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Allelic loss on chromosomes 3p, 5q and 17p in renal cell carcinomas.
    Sugimura J; Tamura G; Suzuki Y; Fujioka T
    Pathol Int; 1997; 47(2-3):79-83. PubMed ID: 9088024
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development.
    Clifford SC; Walsh S; Hewson K; Green EK; Brinke A; Green PM; Gianelli F; Eng C; Maher ER
    Genes Chromosomes Cancer; 1999 Sep; 26(1):20-8. PubMed ID: 10441001
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genome-wide analysis of recurrent copy-number alterations and copy-neutral loss of heterozygosity in head and neck squamous cell carcinoma.
    Marescalco MS; Capizzi C; Condorelli DF; Barresi V
    J Oral Pathol Med; 2014 Jan; 43(1):20-7. PubMed ID: 23750501
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comprehensive loss of heterozygosity analysis and identification of a novel hotspot at 3p21 in salivary gland neoplasms.
    Honjo N; Gunduz M; Fukushima K; Cengiz B; Beder LB; Gunduz E; Nagatsuka H; Xiao J; Shimizu K; Nishizaki K
    Otolaryngol Head Neck Surg; 2007 Jul; 137(1):119-25. PubMed ID: 17599578
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detailed deletion mapping of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis.
    Xu XF; Gao YN; Cheng SJ
    Chin Med J (Engl); 2004 Aug; 117(8):1204-9. PubMed ID: 15361296
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Microsatellite instability and loss of heterozygosity in squamous cell carcinoma of the head and neck].
    Xiao L; Iol N; Luo Z
    Hua Xi Yi Ke Da Xue Xue Bao; 2001 Sep; 32(3):372-5. PubMed ID: 12536567
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Absence of mutations in the VHL gene but frequent loss of heterozygosity at 3p25-26 in non-small cell lung carcinomas.
    Miyakis S; Liloglou T; Kearney S; Xinarianos G; Spandidos DA; Field JK
    Lung Cancer; 2003 Mar; 39(3):273-7. PubMed ID: 12609565
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hypermethylation and loss of heterozygosity of tumor suppressor genes on chromosome 3p in cervical cancer.
    Choi CH; Lee KM; Choi JJ; Kim TJ; Kim WY; Lee JW; Lee SJ; Lee JH; Bae DS; Kim BG
    Cancer Lett; 2007 Sep; 255(1):26-33. PubMed ID: 17467893
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Frequent loss of heterozygosity at 3p25-p26 is associated with invasive oral squamous cell carcinoma.
    Kayahara H; Yamagata H; Tanioka H; Miki T; Hamakawa H
    J Hum Genet; 2001; 46(6):335-41. PubMed ID: 11393537
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular genetic investigations of the mechanism of tumourigenesis in von Hippel-Lindau disease: analysis of allele loss in VHL tumours.
    Crossey PA; Foster K; Richards FM; Phipps ME; Latif F; Tory K; Jones MH; Bentley E; Kumar R; Lerman MI
    Hum Genet; 1994 Jan; 93(1):53-8. PubMed ID: 8270255
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of fibronectin and HIF-1alpha in renal cell carcinomas: relationship to von Hippel-Lindau gene inactivation.
    He Z; Liu S; Guo M; Mao J; Hughson MD
    Cancer Genet Cytogenet; 2004 Jul; 152(2):89-94. PubMed ID: 15262424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.